Degenerative Lumbar Spondylolisthesis

0
Pipeline Programs
1
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Olympus
OlympusPA - Center Valley
3 programs
Spinal fusionN/A1 trial
Study of OP-1 Putty in Uninstrumented Posterolateral FusionsN/A1 trial
Use of OP-1 Putty in Uninstrumented posterolateral fusionN/A1 trial
Active Trials
NCT00677950Completed336Est. Nov 2005
NCT00678353Completed202Est. Aug 2007
NCT00679107Completed48Est. Jul 2005

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
OlympusStudy of OP-1 Putty in Uninstrumented Posterolateral Fusions
OlympusSpinal fusion
OlympusUse of OP-1 Putty in Uninstrumented posterolateral fusion

Clinical Trials (3)

Total enrollment: 586 patients across 3 trials

NCT00678353OlympusStudy of OP-1 Putty in Uninstrumented Posterolateral Fusions

Study of OP-1 Putty in Uninstrumented Posterolateral Fusions

Start: May 2007Est. completion: Aug 2007202 patients
N/ACompleted
NCT00677950OlympusSpinal fusion

OP-1 Putty for Posterolateral Fusions

Start: Oct 2001Est. completion: Nov 2005336 patients
N/ACompleted
NCT00679107OlympusUse of OP-1 Putty in Uninstrumented posterolateral fusion

A Prospective Pilot Study of the OP-1 Putty in Uninstrumented Posterolateral Fusions

Start: Jun 1999Est. completion: Jul 200548 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space